Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Patient blood management as the standard of care

Michael F. Murphy, Antony Palmer

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 583–589.

https://doi.org/10.1182/hematology.2019000063

Published: 2019

Journal Articles

Complications in pregnant women with sickle cell disease

Kim Smith-Whitley

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 359–366.

https://doi.org/10.1182/hematology.2019000039

Published: 2019

Journal Articles

Clinical decision support and improved blood use in patient blood management

Lawrence Tim Goodnough, Marie A. Hollenhorst

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 577–582.

https://doi.org/10.1182/hematology.2019000062

Published: 2019

Journal Articles

What is the role of screening for pulmonary hypertension in adults and children with sickle cell disease?

Shaina M. Willen, Mark T. Gladwin

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 431–434.

https://doi.org/10.1182/asheducation-2017.1.431

Published: 2017

Journal Articles

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Michael R. DeBaun, Allison A. King

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 632–639.

https://doi.org/10.1182/asheducation-2016.1.632

Published: 2016

Journal Articles

Sickle cell disease: when and how to transfuse

Jo Howard

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 625–631.

https://doi.org/10.1182/asheducation-2016.1.625

Published: 2016

Journal Articles

Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

Hetty E. Carraway

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 470–477.

https://doi.org/10.1182/asheducation-2016.1.470

Published: 2016

Journal Articles

The five key things you need to know to manage adult patients with sickle cell disease

Sophie Lanzkron, Carlton Haywood, Jr

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 420–425.

https://doi.org/10.1182/asheducation-2015.1.420

Published: 2015

Journal Articles

Optimizing hydroxyurea therapy for sickle cell anemia

Russell E. Ware

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 436–443.

https://doi.org/10.1182/asheducation-2015.1.436

Published: 2015

Journal Articles

Implementing a blood utilization program to optimize transfusion practice

William Savage

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 444–447.

https://doi.org/10.1182/asheducation-2015.1.444

Published: 2015

Journal Articles

Established and novel agents for myelodysplastic syndromes

Mikkael A. Sekeres, Aaron T. Gerds

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 82–89.

https://doi.org/10.1182/asheducation-2014.1.82

Published: 2014

Journal Articles

Bloodless medicine: what to do when you can't transfuse

Linda M.S. Resar, Steven M. Frank

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 553–558.

https://doi.org/10.1182/asheducation-2014.1.553

Published: 2014

Journal Articles

Pharmacologic tools to reduce bleeding in surgery

Sam Schulman

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 517–521.

https://doi.org/10.1182/asheducation.V2012.1.517.3798536

Published: 2012

Journal Articles

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

Michael R. DeBaun

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 427–433.

https://doi.org/10.1182/asheducation-2011.1.427

Published: 2011

Journal Articles

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Jeffrey D. Lebensburger, Michael R. DeBaun, Alexis A. Thompson

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 440–442.

https://doi.org/10.1182/asheducation-2011.1.440

Published: 2011

Journal Articles

Real-World Use of Iron Chelators

Janet L. Kwiatkowski

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 451–458.

https://doi.org/10.1182/asheducation-2011.1.451

Published: 2011

Journal Articles

Parenteral Iron Therapy in Cancer-Associated Anemia

David H. Henry

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 351–356.

https://doi.org/10.1182/asheducation-2010.1.351

Published: 2010

Journal Articles

Hb H disease: clinical course and disease modifiers

Suthat Fucharoen, Vip Viprakasit

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 26–34.

https://doi.org/10.1182/asheducation-2009.1.26

Published: 2009

Journal Articles

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Heather A. Leitch, Linda M. Vickars

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 664–672.

https://doi.org/10.1182/asheducation-2009.1.664

Published: 2009

Journal Articles

Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes

Mario Cazzola, Matteo G. Della Porta, Luca Malcovati

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 166–175.

https://doi.org/10.1182/asheducation-2008.1.166

Published: 2008

NARROW

Patient blood management as the standard of care

Complications in pregnant women with sickle cell disease

Clinical decision support and improved blood use in patient blood management

What is the role of screening for pulmonary hypertension in adults and children with sickle cell disease?

Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative

Sickle cell disease: when and how to transfuse

Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

The five key things you need to know to manage adult patients with sickle cell disease

Optimizing hydroxyurea therapy for sickle cell anemia

Implementing a blood utilization program to optimize transfusion practice

Established and novel agents for myelodysplastic syndromes

Bloodless medicine: what to do when you can't transfuse

Pharmacologic tools to reduce bleeding in surgery

Secondary Prevention of Overt Strokes in Sickle Cell Disease: Therapeutic Strategies and Efficacy

What Is the Evidence for Using Hydroxyurea for Secondary Stroke Prevention?

Real-World Use of Iron Chelators

Parenteral Iron Therapy in Cancer-Associated Anemia

Hb H disease: clinical course and disease modifiers

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only